GREY:ATBPF - Post by User
Comment by
Bobwinson Apr 21, 2018 11:02pm
169 Views
Post# 27922659
RE:RE:RE:WOW ATE TARGET 1.40 !!!!
RE:RE:RE:WOW ATE TARGET 1.40 !!!! The analyst gave a 1 year price target of C$1.40 so it's not that unreasonable. In the analysis there are pluses and minuses. He used a royalty rate of up to 30% so income is much higher after commercialization BUT he uses 2024 as the approval and commercialization date. This is far later than Zack's date of 2021. In order for Antibe to get that high a royalty rate, they would probably have to finance the phase III trials themselves. Given the company's preference for finding a phase III partner to finance the trials, this seems odd.